2021
Location Bensheim IDK 2.0
Only 800 metres away from our main building in Stubenwald-Allee, we have commissioned our new production and warehouse building in Sophie-Opel Straße.
„We work for a world in which diseases are diagnosed in time. Yesterday, we developed analytical methods that are now routinely used throughout laboratory diagnostics. Today, we are developing tests for basic and applied research that will help predict and prevent disease in the future. Identifying disease risks, making accurate predictions, initiating preventive measures and continuously monitoring them - this is where the future lies."
Dr. Franz Paul Armbruster - CEO Immundiagnostik AG
Immundiagnostik AG was founded by Dr. Franz Paul Armbruster in 1986 and is now an internationally active diagnostics company with representatives in over 70 countries. The focus of our work is the development and production of innovative immunoassays, LC-MS/MS, HPLC, PCR and other analytical detection methods for medical routine and research. In addition, you will find a wide range of antibodies and antigens in our portfolio. Further services like proficiency testing or contract developments complete our program.
Only 800 metres away from our main building in Stubenwald-Allee, we have commissioned our new production and warehouse building in Sophie-Opel Straße.
The North American subsidiary, Immundiagnostik, Inc. located in Manchester, NH was founded in 2018 by Dr. Franz Paul Armbruster, Jennifer Mayes, Terry Fisher and Dr. Karl Florian Wintgens.
QuantOn® technology established as a leading cutting-edge technology for point-of-care diagnostics.
Immundiagnostik, Inc. is the North American subsidiary of Immundiagnostik AG.
Independent spin-off company by Immundiagnostik AG. Development and sales of software for diagnostics.
The globally oriented Preventis GmbH focuses on point-of-care diagnostics and telemedical solutions, primarily in the fields of gastroenterology, infectious diseases, reproductive medicine and oncology.
International, fully peer-reviewed journal covering all aspects of laboratory medicine, transfusion medicine, and cell therapy.
Development of pharmaceuticals and treatments with human relaxin-2 for chronic cardiovascular diseases and (pre-)diabetic conditions.